ALT5 Sigma Corp reported that David Danziger resigned from the Board on November 25, 2025, leading to non-compliance with Nasdaq listing rules regarding the Audit Committee. The company plans to appoint an additional independent director before the compliance cure period ends on November 25, 2026.